BSECompany Update6 Aug 2026 · 6 Aug 2026, 08:27 pm

Statement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June 30, 2026.

HealthCare Global Enterprises Ltd · 539787

✦ AI SummaryFundraise

HealthCare Global Enterprises Ltd has filed a statement confirming no deviation or variation in the utilisation of proceeds raised through the Rights Issue for the quarter ended June 30, 2026, from the objects stated in the Letter of Offer dated February 24, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

HealthCare Global Enterprises Ltd - 539787 - Statement Of Variation Or Deviation Of The Proceeds Of Rights Issue For The Quarter Ended June 30, 2026.

Attachments (1)

📄

92754386-e536-4261-a6fe-71096b3c537a.pdf

pdf

Download →
View document text
August 06, 2026 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam, Subject : Statement of deviation or variation for funds raised through Rights Issue for the quarter ended June 30, 2026 Stock Code : BSE – 539787, NSE – HCG Reference : Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD1/162/2019 dated December 24, 2019 (“Listing Regulations”). Pursuant to the Listing Regulations, we hereby confirm that there was no deviation or variation in the utilisation of the proceeds raised through the Rights Issue of the Company during the quarter ended June 30, 2026, from the objects stated in the Letter of Offer dated February 24, 2026. In this regard, please find enclosed herewith, as Annexure, the statement confirming that there was no deviation or variation in the utilisation of the aforesaid proceeds for the quarter ended June 30, 2026, from the objects stated in the Letter of Offer, in accordance with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019. The said statement has been duly reviewed by the Audit Committee of the Company. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/ You are requested to take the information on record. Thanking You, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary and Compliance Officer Encl: As above HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag ANNEXURE The additional disclosures as required under the Listing Regulations and SEBI Circular no. CIR/CFD/CMD1/162/2019 dated December 24, 2019, as amended from time to time, with respect to statement of deviation or variation in the utilisation of funds raised through Rights Issue for the quarter ended June 30, 2026. Name of Listed Entity HealthCare Global Enterprises Limited Mode of Fund Raising Public Issues / Rights Issues / Preferential Issues / QIP / Others Date of Raising Funds March 27, 2026 Amount Raised Rs. 424,68,17,792 (Indian Rupees Four Hundred Twenty-Four Crore Sixty-Eight Lakh Seventeen Thousand Seven Hundred and Ninety-Two Only) Report filed for the quarter ended June 30, 2026 Monitoring Agency Applicable / Not applicable Monitoring Agency Name, if applicable CARE Ratings Limited Is there a Deviation / Variation in use of funds Yes / No raised. If yes, whether the same is pursuant to change in Not Applicable terms of a contract or objects, which was approved by the shareholders. If Yes, Date of shareholder Approval Not Applicable Explanation for the Deviation / Variation Not Applicable Comments of the Audit Committee after review No comments Comments of the auditors, if any No comments HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag Objects for which funds have been raised and where there has been a deviation, in the following table Original Object Modified Original Modified Funds Amount of Remarks Object, if Allocation allocation, Utilised Deviation/Variation if any any (Rs in if any for the quarter Crores) according to applicable object Pre-payment and/or N.A. 170.00 Nil 170.00 Nil repayment of all, or a portion of, certain outstanding borrowings availed by Company and wholly owned Subsidiary HCG NCHRI Oncology Part-payment of N.A. 154.04 Nil 154.04 Nil consideration for acquisition of 34.00% additional stake in equity share capital of Vizag Hospital and Cancer Research Center Private Limited, one of existing Subsidiaries. General Corporate N.A. 95.57 Nil 95.83* Nil As Purposes detailed in the Issue related expenses N.A. 5.07 Nil 4.81* Nil Note below TOTAL 424.68 424.68 Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc. *Note: The actual Issue Related Expenses incurred were Rs. 4.81 crore as against the estimated allocation of Rs. 5.07 crore. Consequently, the unutilized amount of Rs. 0.26 crore was utilized towards General Corporate Purposes, resulting in utilization of Rs. 95.83 crore (which is less than 25% of the total issue size) under General Corporate Purposes as compared to the originally allocated amount of Rs. 95.57 crore. There was no change in the overall utilization of the net proceeds from the Issue. Please note that the aforesaid utilization is in accordance with the disclosures set out in the Offer Document and is within the overall limit prescribed under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag